ArticleVeterinary world2025
Innovative use of squid (
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Infectious myonecrosis virus (IMNV) is a significant pathogen affecting Materials and Methods: A completely randomized design was employed, with five groups: a negative control (healthy shrimp), a positive control (IMNV-infected), and three treatment groups that received squid ink powder at 400, 500, and 600 mg/kg feed, respectively. The feed was administered before and after IMNV immersion challenge. Immune parameters assessed included total hemocyte count (THC), differential hemocyte count (DHC), respiratory burst (RB), phenoloxidase (PO), superoxide dismutase (SOD), phagocytic activity, and ribonucleotide reductase (RR) expression. Statistical analysis was conducted using a one-way analysis of variance with Duncan's Results: The 500 mg/kg dose of squid ink powder significantly enhanced shrimp immunity post-IMNV challenge. This treatment yielded the highest THC (6 × 10 Conclusion: Squid ink powder at 500 mg/kg feed significantly enhances the non-specific immune system in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.